With FDA approval of Wegovy pill, new era of oral GLP-1 weight loss drugs begins

The US Food and Drug Administration on Monday approved a daily pill version of Novo Nordisk’s weight-loss drug Wegovy, ...
The White House

ONDCP Releases Trump Administration’s Statement of Drug Policy Priorities

Today, the White House Office of National Drug Control Policy (ONDCP) is announcing the release of the Trump Administration’s Drug Policy Priorities, a comprehensive and coordinated blueprint to ...

European Medicines Agency (EMA): Role, Functions and Significance

Discover the EMA's role in promoting safe medicine access in the EU. Learn about its responsibilities in drug evaluation, ...
The New England Journal of Medicine

Discovery of GLP-1–Based Drugs for the Treatment of Obesity

Since the pioneering discovery of secretin-like activity by Bayliss and Starling in 1902, scientists have pursued the mysteries of gut-hormone biology, such that the peptide hormone–secreting ...